In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals
White blood cells are essential for fighting infection and disease, and for keeping your body healthy
If you have concerns about your current treatment plan or wish to explore FDA-compliant alternatives for surgical recovery and health optimization, we encourage you to reach out to our team
One injection
All participants received a lifestyle intervention involving regular counselling regarding diet and physical activity
CAR domains were comprised of CD8 leader, anti-muFAP scFV, CD8 hinge, CD28 transmembrane (TMD) and 4-1BB & CD3 intracellular signal
